SCHEMBL6286367

SCHEMBL6286367

SCc1ccc(-c2nc(-c3ccc(Cl)cc3)c(-c3ccncc3)s2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.48
KDM4E B2RXH2 3/20 0.44
LMNA P02545 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
IDO1 P14902 3/20 0.44
TDO2 P48775 2/20 0.44
CDC7 O00311 5/20 0.42
DBF4 Q9UBU7 5/20 0.42
MAPK14 Q16539 1/20 0.42
ALOX5 P09917 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
LSS P48449 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6276676 0.86 PTGS2 (0.64) PTGS2KDM4EIDO1TDO2CDC7
SCHEMBL15690382 0.86 PTGS2 (0.50) PTGS2KDM4ELMNARAB9ASMN1; SMN2
SCHEMBL6286370 0.85 MEN1 (0.50) PTGS2KDM4ELMNARAB9ASMN1; SMN2
SCHEMBL6280962 0.83 PTGS2 (0.48) PTGS2KDM4ELMNARAB9ASMN1; SMN2
SCHEMBL6279375 0.83 PTGS2 (0.54) PTGS2KDM4ELMNARAB9ASMN1; SMN2
SCHEMBL6600796 0.82 PTGS2 (0.49) PTGS2KDM4ELMNARAB9ASMN1; SMN2
SCHEMBL6283249 0.82 MAPK14 (0.54) PTGS2IDO1TDO2CDC7DBF4
SCHEMBL6283027 0.81 MAPK14 (0.50) PTGS2KDM4ELMNARAB9AIDO1
SCHEMBL6505966 0.80 PTGS2 (0.50) PTGS2KDM4ELMNARAB9ASMN1; SMN2
SCHEMBL6575979 0.80 PTGS2 (0.47) PTGS2KDM4ELMNARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1205478-A1 p38MAP KINASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2002-05-15 EP claimed
US-6962933-B1 Method for inhibiting p38 MAP kinase or TNF-α production using a 1,3-thiazole TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-11-08 US disclosed
EP-1205478-A1 p38MAP KINASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2002-05-15 EP disclosed